← Back to Search

Device

Sundt Carotid Shunt for Carotid Artery Stenosis

N/A
Waitlist Available
Research Sponsored by Integra LifeSciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 60 days post-procedure
Awards & highlights
No Placebo-Only Group

Summary

The primary objective of this study is to retrospectively investigate the safety and efficacy of the Integra Sundt™ carotid shunt during endarterectomy procedures.

Eligible Conditions
  • Carotid Artery Stenosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 60 days post-procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 60 days post-procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evidence of Injury to the Artery or Cerebral Ischemia Secondary to Shunt Placement and Removal

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Sundt Carotid ShuntExperimental Treatment1 Intervention
Subject has undergone a endarterectomy procedure with the use of the Sundt Carotid Shunt.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sundt carotid shunt
2019
N/A
~100

Find a Location

Who is running the clinical trial?

Integra LifeSciences CorporationLead Sponsor
108 Previous Clinical Trials
11,194 Total Patients Enrolled
Andrew TummonStudy DirectorIntegra LifeSciences
6 Previous Clinical Trials
624 Total Patients Enrolled
~15 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top